Skip to main content
logo
Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.340
-0.030 (-0.89%)
Aug 15, 2025, 2:58 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Novel Therapeutics
18.14M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-53.51%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
18.14M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-53.51%
Log In
Log In
Log In
Log In
Upgrade